|
In addition to Labopharm, Ms. Brown currently serves as director of a number of health sciences companies, including Tanox Inc., Mediquest Therapeutics, Inc., and Rx3 Pharmaceuticals. She also serves on the boards of the UCSD Foundation, the La Jolla Institute for Molecular Medicine, the Veteran's Medical Research Foundation, and CONNECT. She is a member of Tech Coast Angels, an organization that provides early stage financing and managerial assistance to technology and life-science entrepreneurs.
Ms. Brown has an extensive and diverse background in the life-sciences industry, including biotechnology, pharmaceuticals and drug delivery, as well as specific experience in pharmaceutical sales and marketing. From 2000 to 2003, Ms. Brown was Executive Vice President of Amylin Pharmaceuticals, Inc. where she was responsible for commercial operations. She continues to serve as an Advisor to the CEO. Previously, she was Executive Vice President of Dura Pharmaceuticals. Prior to joining Dura, she was with Eli Lilly and Company for more that 25 years in progressively more senior roles. | 